Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Merkel

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Blood|March 18, 2021
MARCKS affects cell motility and response to BTK inhibitors in CLLLaura Beckmann, Valeska Berg, Clarissa Dickhut, et al.
Leukemia|March 29, 2018
The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphomaNikolai Schleussner, Olaf Merkel, Mariantonia Costanza, et al.
Blood|March 28, 2022
Extracellular vesicles and PD-L1 suppress macrophages, inducing therapy resistance in TP53-deficient B-cell malignanciesElena Izquierdo, Daniela Vorholt, Stuart Blakemore, et al.
Blood|September 15, 2018
Katerina Musilova, Jan Devan, Katerina Cerna, et al.
Nature Communications|February 22, 2018
Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemiaCarmen D Herling, Nima Abedpour, Jonathan Weiss, et al.
Leukemia|August 23, 2018
Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphomaNicole Prutsch, Elisabeth Gurnhofer, Tobias Suske, et al.
Leukemia|July 16, 2020
Correction: Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphomaNicole Prutsch, Elisabeth Gurnhofer, Tobias Suske, et al.
Haematologica|April 25, 2020
Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic targetHugo Larose, Nina Prokoph, Jamie D Matthews, et al.
Molecular Cancer|May 29, 2024
JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progressionTorben Redmer, Martin Raigel, Christina Sternberg, et al.
The Lancet. Haematology|November 21, 2017
Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot studyBerend Snijder, Gregory I Vladimer, Nikolaus Krall, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Blood|March 18, 2021
MARCKS affects cell motility and response to BTK inhibitors in CLLLaura Beckmann, Valeska Berg, Clarissa Dickhut, et al.
Leukemia|March 29, 2018
The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphomaNikolai Schleussner, Olaf Merkel, Mariantonia Costanza, et al.
Blood|March 28, 2022
Extracellular vesicles and PD-L1 suppress macrophages, inducing therapy resistance in TP53-deficient B-cell malignanciesElena Izquierdo, Daniela Vorholt, Stuart Blakemore, et al.
Blood|September 15, 2018
Katerina Musilova, Jan Devan, Katerina Cerna, et al.
Nature Communications|February 22, 2018
Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemiaCarmen D Herling, Nima Abedpour, Jonathan Weiss, et al.
Leukemia|August 23, 2018
Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphomaNicole Prutsch, Elisabeth Gurnhofer, Tobias Suske, et al.
Leukemia|July 16, 2020
Correction: Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphomaNicole Prutsch, Elisabeth Gurnhofer, Tobias Suske, et al.
Haematologica|April 25, 2020
Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic targetHugo Larose, Nina Prokoph, Jamie D Matthews, et al.
Molecular Cancer|May 29, 2024
JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progressionTorben Redmer, Martin Raigel, Christina Sternberg, et al.
The Lancet. Haematology|November 21, 2017
Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot studyBerend Snijder, Gregory I Vladimer, Nikolaus Krall, et al.
Pageof 6